University & Research Institutions

Why 2021 will be a pivotal year for life sciences patents in China

Despite radical reforms, pharma and biotech innovators still have unanswered questions about the country’s IP system

Why 2021 will be a pivotal year for life sciences patents in China
Six life sciences IP dealmaking trends to watch out for in 2021
19 Jan 2021

Six life sciences IP dealmaking trends to watch out for in 2021

Despite a turbulent 2020 for pharma transactions, it is possible to discern a few patterns for activity in the market this year

Elite US universities come together to break technology licensing “logjam”
18 Jan 2021

Elite US universities come together to break technology licensing “logjam”

A group of 15 leading institutions, led by Columbia, is hoping that a new pool will unlock more value from their patents and help change the mindset of Big Tech

Latest

View all
14 Jan 2021

New Brazilian biotech patent examination guidelines a “missed opportunity”

While boosting transparency, the many difficulties faced by life sciences innovators when applying for protection in the country are not addressed Read more

12 Jan 2021

Newly-passed Orange Book law leaves the big questions unanswered

Clearing up remaining uncertainties over FDA patent listings will be the subject of intense debate in the US over coming months Read more

8 Jan 2021

South Korea's Intellectual Discovery is in the process of becoming a big league, mainstream NPE

A year after a major capital infusion and a change of leadership, the firm has notched some notable settlements in the US and laid the groundwork for new assertion campaigns Read more

22 Dec 2020

Three life sciences trade secrets and data strategy lessons

As non-patent assets become increasingly important, pharma and biotech innovators must adapt their IP strategies. Read more

News

View all
15 Dec 2020

East Asian giants leave their stamp on the IP market

IAM reveals the Asia IP Elite members for 2020 from two dynamic high-tech jurisdictions: South Korea and Taiwan Read more

14 Dec 2020

The Asia IP Elite – a shared commitment to excellence across very different markets

IAM reveals the top in-house IP teams from India, Southeast Asia and Australasia Read more

19 Nov 2020

Your guide to covid-19 vaccine stakeholders’ IP strategies

IAM examines the approaches taken by – and the issues facing – the leading companies in the race to find effective coronavirus inoculations Read more

24 Oct 2020

To educate lawyers who change the world, we cannot let this crisis go to waste

As the covid-19 pandemic continues to upend education in the US and beyond, there is an opportunity to create a new normal in how IP is taught, says Megan Carpenter, Dean of the Franklin Pierce School of Law Read more

Analysis

View all
16 Dec 2020

Five key insights into 2020’s drug royalty transactions

It has been a year of creative and flexible deal-making with many life sciences entities taking advantage of the revenues this kind of IP monetisation can deliver Read more

8 Dec 2020

Australian vaccine patent ruling shows tough new support requirements for life sciences innovators

Wyeth’s dispute with MSD underscores move towards stricter, UK-style disclosure obligations for IP rights Read more

3 Dec 2020

New patent politics put US public-private partnerships under threat, says BIO’s IP chief

In an exclusive interview, Hans Sauer talks of concerns over a shift in federal strategy and argues that government research funding should not be seen as a commercial investment Read more

30 Nov 2020

PARC goes on patent offensive against Facebook, Snap and Twitter

Very rare assertion campaign by the Xerox subsidiary sees three suits filed in US district court against social media giants Read more

Insights

View all
12 Aug 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in May, June and July Read more

12 Aug 2020

As the fallout from covid continues, the two IP superpowers offer different messages

While China cheers an uptick in applications, the USPTO warns of a prolonged downturn Read more

8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more

24 May 2019

IP market news highlights

Some of the major news stories carried on the IAM platform from March to mid-May. Read more